6101 - 6125 of 7877 Results
Title
Year
- Alterations in striato-thalamo-pallidal intrinsic functional connectivity as a prodrome of Parkinson's disease2017OPENTitle: Alterations in striato-thalamo-pallidal intrinsic functional connectivity as a prodrome of Parkinson's diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 16Issue #:Start Page: 313End Page: 318Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2017.08.003Best OA location URL: https://doi.org/10.1016/j.nicl.2017.08.003Citation Count: 30
-
RESTRICTEDTitle: Association between Various Brain Pathologies and Gait DisturbanceJournal Name: Dementia and Geriatric Cognitive DisordersPublisher: S. Karger AGVol: 43Issue #: 3-4Start Page: 128End Page: 143Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1159/000456541Best OA location URL: https://www.karger.com/Article/Pdf/456541Citation Count: 45
-
OPENTitle: Biomonitorization of iron accumulation in the substantia nigra from Lewy body disease patientsJournal Name: Toxicology ReportsPublisher: Elsevier BVVol: 4Issue #:Start Page: 188End Page: 193Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.toxrep.2017.03.005Best OA location URL: https://doi.org/10.1016/j.toxrep.2017.03.005Citation Count: 23
-
RESTRICTEDTitle: Chaperone-Based Therapies for Disease Modification in Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: Hindawi LimitedVol: 2017Issue #:Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1155/2017/5015307Best OA location URL: http://downloads.hindawi.com/journals/pd/2017/5015307.pdfCitation Count: 34
- Chronic exposure to dopamine agonists affects the integrity of striatal D 2 receptors in Parkinson's patients2017OPENTitle: Chronic exposure to dopamine agonists affects the integrity of striatal D 2 receptors in Parkinson's patientsJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 16Issue #:Start Page: 455End Page: 460Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2017.08.013Best OA location URL: https://doi.org/10.1016/j.nicl.2017.08.013Citation Count: 33
- Cutaneous Autonomic Pilomotor Testing to Unveil the Role of Neuropathy Progression in Early Parkinson’s Disease (CAPTURE PD): Protocol for a Multicenter Study2017OPENTitle: Cutaneous Autonomic Pilomotor Testing to Unveil the Role of Neuropathy Progression in Early Parkinson’s Disease (CAPTURE PD): Protocol for a Multicenter StudyJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2017.00212Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2017.00212/pdfCitation Count: 15
-
OPENTitle: Distinct alterations in Parkinson's medication-state and disease-state connectivityJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 16Issue #:Start Page: 575End Page: 585Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2017.09.004Best OA location URL: https://doi.org/10.1016/j.nicl.2017.09.004Citation Count: 41
-
RESTRICTEDTitle: Divalent metal ions control activity and inhibition of protein kinasesJournal Name: MetallomicsPublisher: Oxford University Press (OUP)Vol: 9Issue #: 11Start Page: 1576End Page: 1584Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1039/c7mt00204aCitation Count: 47
-
OPENTitle: Dual-Task Performance in GBA Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: Hindawi LimitedVol: 2017Issue #:Start Page: 1End Page: 6Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2017/8582740Best OA location URL: http://downloads.hindawi.com/journals/pd/2017/8582740.pdfCitation Count: 3
- Evidence for an Additive Neurorestorative Effect of Simultaneously Administered CDNF and GDNF in Hemiparkinsonian Rats: Implications for Different Mechanism of Action2017OPENTitle: Evidence for an Additive Neurorestorative Effect of Simultaneously Administered CDNF and GDNF in Hemiparkinsonian Rats: Implications for Different Mechanism of ActionJournal Name: eneuroPublisher: Society for NeuroscienceVol: 4Issue #: 1Start Page: ENEURO.0117End Page: 16.2017Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1523/eneuro.0117-16.2017Best OA location URL: https://www.eneuro.org/content/eneuro/4/1/ENEURO.0117-16.2017.full.pdfCitation Count: 49
-
OPENTitle: Functional connectivity disruptions correlate with cognitive phenotypes in Parkinson's diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 14Issue #:Start Page: 591End Page: 601Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2017.03.002Best OA location URL: https://doi.org/10.1016/j.nicl.2017.03.002Citation Count: 96
- Improved prediction of outcome in Parkinson's disease using radiomics analysis of longitudinal DAT SPECT images2017OPENTitle: Improved prediction of outcome in Parkinson's disease using radiomics analysis of longitudinal DAT SPECT imagesJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 16Issue #:Start Page: 539End Page: 544Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nicl.2017.08.021Best OA location URL: https://doi.org/10.1016/j.nicl.2017.08.021Citation Count: 88
- Interview with Mark Frasier: a Michael J Fox Foundation perspective on precision medicine in Parkinson's2017OPENTitle: Interview with Mark Frasier: a Michael J Fox Foundation perspective on precision medicine in Parkinson'sJournal Name: Personalized MedicinePublisher: Informa UK LimitedVol: 14Issue #: 1Start Page: 13End Page: 15Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2217/pme-2016-0087Best OA location URL: https://www.futuremedicine.com/doi/pdf/10.2217/pme-2016-0087Citation Count: 0
-
OPENTitle: Major Shifts in Glial Regional Identity Are a Transcriptional Hallmark of Human Brain AgingJournal Name: Cell ReportsPublisher: Elsevier BVVol: 18Issue #: 2Start Page: 557End Page: 570Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.celrep.2016.12.011Best OA location URL: https://doi.org/10.1016/j.celrep.2016.12.011Citation Count: 346
-
OPENTitle: PINK1 Primes Parkin-Mediated Ubiquitination of PARIS in Dopaminergic Neuronal SurvivalJournal Name: Cell ReportsPublisher: Elsevier BVVol: 18Issue #: 4Start Page: 918End Page: 932Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2016.12.090Best OA location URL: http://www.cell.com/article/S2211124716318125/pdfCitation Count: 162
- Predicting primary progressive aphasias with support vector machine approaches in structural MRI data2017OPENTitle: Predicting primary progressive aphasias with support vector machine approaches in structural MRI dataJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 14Issue #:Start Page: 334End Page: 343Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2017.02.003Best OA location URL: https://doi.org/10.1016/j.nicl.2017.02.003Citation Count: 44
-
RESTRICTEDTitle: Protective effects of fisetin and other berry flavonoids in Parkinson's diseaseJournal Name: Food & FunctionPublisher: Royal Society of Chemistry (RSC)Vol: 8Issue #: 9Start Page: 3033End Page: 3042Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1039/c7fo00809kCitation Count: 59
- Refining diagnosis of Parkinson's disease with deep learning-based interpretation of dopamine transporter imaging2017OPENTitle: Refining diagnosis of Parkinson's disease with deep learning-based interpretation of dopamine transporter imagingJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 16Issue #:Start Page: 586End Page: 594Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2017.09.010Best OA location URL: https://doi.org/10.1016/j.nicl.2017.09.010Citation Count: 148
-
RESTRICTEDTitle: Should Skin Biopsies Be Performed in Patients Suspected of Having Parkinson’s Disease?Journal Name: Parkinson's DiseasePublisher: Hindawi LimitedVol: 2017Issue #:Start Page: 1End Page: 6Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1155/2017/6064974Best OA location URL: http://downloads.hindawi.com/journals/pd/2017/6064974.pdfCitation Count: 7
- Subthalamic Nucleus Deep Brain Stimulation in Early Stage Parkinson’s Disease Is Not Associated with Increased Body Mass Index2017OPENTitle: Subthalamic Nucleus Deep Brain Stimulation in Early Stage Parkinson’s Disease Is Not Associated with Increased Body Mass IndexJournal Name: Parkinson's DiseasePublisher: Hindawi LimitedVol: 2017Issue #:Start Page: 1End Page: 4Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2017/7163801Best OA location URL: http://downloads.hindawi.com/journals/pd/2017/7163801.pdfCitation Count: 5
- Unconventional neurotrophic factors CDNF and MANF: Structure, physiological functions and therapeutic potential2017RESTRICTEDTitle: Unconventional neurotrophic factors CDNF and MANF: Structure, physiological functions and therapeutic potentialJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 97Issue #:Start Page: 90End Page: 102Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2016.07.009Citation Count: 149
-
RESTRICTEDTitle: Urate as a Marker of Risk and Progression of Neurodegenerative DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 14Issue #: 1Start Page: 148End Page: 153Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-016-0497-4Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-016-0497-4.pdfCitation Count: 74
- The Association Between Plasma Ceramides and Sphingomyelins and Risk of Alzheimer’s Disease Differs by Sex and APOE in the Baltimore Longitudinal Study of Aging2016OPENTitle: The Association Between Plasma Ceramides and Sphingomyelins and Risk of Alzheimer’s Disease Differs by Sex and APOE in the Baltimore Longitudinal Study of AgingJournal Name: Journal of Alzheimer's DiseasePublisher: IOS PressVol: 60Issue #: 3Start Page: 819End Page: 828Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-160925Best OA location URL: https://europepmc.org/articles/pmc5493514?pdf=renderCitation Count: 62
-
OPENTitle: Nrf2 mitigates LRRK2- and α-synuclein–induced neurodegeneration by modulating proteostasisJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 114Issue #: 5Start Page: 1165End Page: 1170Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1522872114Best OA location URL: https://www.pnas.org/content/pnas/114/5/1165.full.pdfCitation Count: 107
-
OPENTitle: Cross-validation of optimized composites for preclinical Alzheimer's diseaseJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 3Issue #: 1Start Page: 123End Page: 129Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.trci.2016.12.001Best OA location URL: https://doi.org/10.1016/j.trci.2016.12.001Citation Count: 23